Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 5 studies | 29% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2509.52 | 2632 / 2642 | 100% | 85.22 | 704 / 705 |
esophagus | 97% | 828.27 | 1398 / 1445 | 82% | 10.40 | 150 / 183 |
skin | 73% | 610.95 | 1329 / 1809 | 99% | 36.64 | 467 / 472 |
uterus | 74% | 304.92 | 126 / 170 | 97% | 24.95 | 446 / 459 |
lung | 88% | 500.66 | 511 / 578 | 79% | 11.31 | 909 / 1155 |
ovary | 64% | 244.92 | 116 / 180 | 99% | 25.19 | 424 / 430 |
intestine | 67% | 262.05 | 650 / 966 | 91% | 14.85 | 481 / 527 |
bladder | 67% | 225.57 | 14 / 21 | 92% | 15.92 | 463 / 504 |
stomach | 46% | 201.09 | 166 / 359 | 88% | 12.51 | 252 / 286 |
breast | 40% | 136.93 | 185 / 459 | 92% | 14.76 | 1033 / 1118 |
prostate | 95% | 542.16 | 233 / 245 | 37% | 2.76 | 184 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.66 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 21.45 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 27.23 | 78 / 80 |
spleen | 88% | 341.24 | 211 / 241 | 0% | 0 | 0 / 0 |
thymus | 52% | 161.26 | 341 / 653 | 29% | 4.67 | 173 / 605 |
lymph node | 0% | 0 | 0 / 0 | 76% | 6.83 | 22 / 29 |
liver | 37% | 160.14 | 84 / 226 | 38% | 4.45 | 156 / 406 |
adrenal gland | 26% | 77.50 | 68 / 258 | 42% | 4.26 | 97 / 230 |
pancreas | 3% | 8.93 | 9 / 328 | 62% | 6.49 | 111 / 178 |
kidney | 40% | 137.64 | 36 / 89 | 24% | 1.90 | 220 / 901 |
peripheral blood | 60% | 273.98 | 560 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 55% | 198.05 | 735 / 1335 | 0% | 0 | 0 / 0 |
adipose | 31% | 95.99 | 373 / 1204 | 0% | 0 | 0 / 0 |
heart | 24% | 71.44 | 204 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 1.82 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031116 | Biological process | positive regulation of microtubule polymerization |
GO_0060236 | Biological process | regulation of mitotic spindle organization |
GO_0045737 | Biological process | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0051301 | Biological process | cell division |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0001578 | Biological process | microtubule bundle formation |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005876 | Cellular component | spindle microtubule |
GO_0030496 | Cellular component | midbody |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0000922 | Cellular component | spindle pole |
GO_0005819 | Cellular component | spindle |
GO_0005737 | Cellular component | cytoplasm |
GO_0008017 | Molecular function | microtubule binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PSRC1 |
Protein name | Proline/serine-rich coiled-coil protein 1 Proline and serine rich coiled-coil 1 |
Synonyms | FP3214 DDA3 |
Description | FUNCTION: Required for normal progression through mitosis. Required for normal congress of chromosomes at the metaphase plate, and for normal rate of chromosomal segregation during anaphase. Plays a role in the regulation of mitotic spindle dynamics. Increases the rate of turnover of microtubules on metaphase spindles, and contributes to the generation of normal tension across sister kinetochores. Recruits KIF2A and ANKRD53 to the mitotic spindle and spindle poles. May participate in p53/TP53-regulated growth suppression. . |
Accessions | ENST00000369909.7 [Q6PGN9-2] ENST00000369904.7 [Q6PGN9-3] S4R3S8 ENST00000474126.2 Q5T2Z0 ENST00000369907.7 [Q6PGN9-2] ENST00000429031.5 ENST00000418914.2 ENST00000369903.6 [Q6PGN9-2] ENST00000409138.6 [Q6PGN9-1] Q5T2Z1 Q6PGN9 ENST00000409267.5 [Q6PGN9-2] |